These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37359014)

  • 41. [Protective effects of combined use of atorvastatin and low molecular weight heparin on the inflammatory reaction and pulmonary functions in rats with sepsis].
    Ren H; Ding M; Ma H; Yao Q; Zuo G; Xu Q; Chu Y; Wang C
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 May; 28(5):427-32. PubMed ID: 29920039
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Screening itself for disseminated intravascular coagulation may reduce mortality in sepsis: A nationwide multicenter registry in Japan.
    Umemura Y; Yamakawa K; Hayakawa M; Hamasaki T; Fujimi S;
    Thromb Res; 2018 Jan; 161():60-66. PubMed ID: 29202320
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Validation of sepsis-induced coagulopathy score in critically ill patients with septic shock: post hoc analysis of a nationwide multicenter observational study in Japan.
    Tanaka C; Tagami T; Kudo S; Takehara A; Fukuda R; Nakayama F; Kaneko J; Ishiki Y; Sato S; Kuno M; Unemoto K
    Int J Hematol; 2021 Aug; 114(2):164-171. PubMed ID: 33895968
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of unfractionated heparin in patients with moderate sepsis-induced coagulopathy: An observational study.
    Ushio N; Yamakawa K; Mochizuki K; Hisamune R; Umemura Y; Takasu A
    Thromb Res; 2024 Sep; 241():109095. PubMed ID: 39024902
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association between hypomagnesemia and coagulopathy in sepsis: a retrospective observational study.
    Tonai K; Katayama S; Koyama K; Sata N; Tomioka Y; Imahase H; Nunomiya S
    BMC Anesthesiol; 2022 Nov; 22(1):359. PubMed ID: 36424547
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recombinant human soluble thrombomodulin and mortality in sepsis-induced disseminated intravascular coagulation. A multicentre retrospective study.
    Hayakawa M; Yamakawa K; Saito S; Uchino S; Kudo D; Iizuka Y; Sanui M; Takimoto K; Mayumi T; Ono K;
    Thromb Haemost; 2016 Jun; 115(6):1157-66. PubMed ID: 26939575
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism.
    Robertson L; Strachan J
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD006771. PubMed ID: 28195640
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical study of low molecular weight heparin therapy for sepsis].
    Ai YH; Zhang LN; Gong H; Xu DM; Zhao SP; Chen JH
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Dec; 17(12):736-9. PubMed ID: 16386181
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy.
    Perrotta C; Chahla J; Badariotti G; Ramos J
    Cochrane Database Syst Rev; 2020 May; 5(5):CD005259. PubMed ID: 32374919
    [TBL] [Abstract][Full Text] [Related]  

  • 50. D-Dimer Levels and the Disseminated Intravascular Coagulation Score to Predict Severity and Outcomes in Sepsis or Septic Shock.
    Schupp T; Weidner K; Rusnak J; Jawhar S; Forner J; Dulatahu F; Brück LM; Hoffmann U; Kittel M; Bertsch T; Akin I; Behnes M
    Clin Lab; 2023 May; 69(5):. PubMed ID: 37145079
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and safety of low-molecular-weight heparin in patients with sepsis: a meta-analysis of randomized controlled trials.
    Fan Y; Jiang M; Gong D; Zou C
    Sci Rep; 2016 May; 6():25984. PubMed ID: 27181297
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial.
    Spyropoulos AC; Goldin M; Giannis D; Diab W; Wang J; Khanijo S; Mignatti A; Gianos E; Cohen M; Sharifova G; Lund JM; Tafur A; Lewis PA; Cohoon KP; Rahman H; Sison CP; Lesser ML; Ochani K; Agrawal N; Hsia J; Anderson VE; Bonaca M; Halperin JL; Weitz JI;
    JAMA Intern Med; 2021 Dec; 181(12):1612-1620. PubMed ID: 34617959
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low molecular weight heparin for prevention of microvascular occlusion in digital replantation.
    Lin PT; Wang SH; Chi CC
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD009894. PubMed ID: 32302004
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Predictive value of sepsis-induced coagulopathy score on 30-day mortality in septic patients].
    Zeng J; Ding H; Zhong W; Li X; Zeng H
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Dec; 34(12):1263-1267. PubMed ID: 36567580
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism.
    Chai-Adisaksopha C; Iorio A; Crowther MA; de Miguel J; Salgado E; Zdraveska M; Fernández-Capitán C; Nieto JA; Barillari G; Bertoletti L; Monreal M;
    Am J Med; 2018 Apr; 131(4):430-437. PubMed ID: 29274307
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of Disseminated Intravascular Coagulation in Critically Ill Pediatric Hemato-oncology Patients with Septic Shock.
    Jhang WK; Park SJ
    Thromb Haemost; 2020 Nov; 120(11):1505-1511. PubMed ID: 32772349
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The prevalence of sepsis-induced coagulopathy in patients with sepsis - a secondary analysis of two German multicenter randomized controlled trials.
    Schmoch T; Möhnle P; Weigand MA; Briegel J; Bauer M; Bloos F; Meybohm P; Keh D; Löffler M; Elke G; Brenner T; Bogatsch H;
    Ann Intensive Care; 2023 Jan; 13(1):3. PubMed ID: 36635426
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Low molecular weight heparin for prevention of central venous catheter-related thrombosis in children.
    Pelland-Marcotte MC; Amiri N; Avila ML; Brandão LR
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD005982. PubMed ID: 32557627
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period.
    Bain E; Wilson A; Tooher R; Gates S; Davis LJ; Middleton P
    Cochrane Database Syst Rev; 2014 Feb; (2):CD001689. PubMed ID: 24519568
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epidemiology of disseminated intravascular coagulation in sepsis and validation of scoring systems.
    Saito S; Uchino S; Hayakawa M; Yamakawa K; Kudo D; Iizuka Y; Sanui M; Takimoto K; Mayumi T; Sasabuchi Y;
    J Crit Care; 2019 Apr; 50():23-30. PubMed ID: 30471557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.